Biomarker prediction of clinical outcome in operable breast cancer patients treated with tamoxifen

The predictivity of tumour size, oestrogen (ER) and progesterone (PgR) receptors, 3H-thymidine labelling index (TLI), c-erbB-2 and p27kip1 expression on clinical outcome was analysed on a consecutive series of 118 postmenopausal patients with ER-positive, node-positive tumours. All patients were tre...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Breast cancer research and treatment 2001-07, Vol.68 (2), p.101-110
Hauptverfasser:	SCARPI, Emanuela, DE PAOLA, Franca, SARTI, Manuela, BAJORKO, Paola, GRANATO, Anna Maria, VOLPI, Annalisa, NANNI, Oriana, MALTONI, Roberta, AMADORI, Dino
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Aged, 80 and over Antineoplastic agents Antineoplastic Agents, Hormonal - therapeutic use Biological and medical sciences Biomarkers, Tumor - metabolism Breast cancer Breast Neoplasms - drug therapy Breast Neoplasms - metabolism Breast Neoplasms - mortality Cancer research Cancer therapies Chemotherapy Chemotherapy, Adjuvant Clinical outcomes Female Gynecology. Andrology. Obstetrics Humans Lymph Nodes - pathology Mammary gland diseases Medical sciences Microfilament Proteins - metabolism Middle Aged Muscle Proteins Pharmacology. Drug treatments Prognosis Receptor, ErbB-2 - metabolism Receptors, Estrogen - metabolism Receptors, Progesterone - metabolism Survival Rate Tamoxifen - therapeutic use Thymidine - metabolism Treatment Outcome Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!